Rational design and biological evaluation of cell-permeant small molecule agonists and antagonists of the NAADP receptor
Lead Research Organisation:
University of Oxford
Department Name: Pharmacology
Abstract
Cells can be thought of as minature factories, with protein machines (enzymes) performing the work and chemical messengers instructing the machines to start, stop, faster slower. The protein machines are built from instructions written in DNA. So, now that the entire humane genome is known, we know the structure of all the machines, but we understand far less about how the machines operate together. A very powerful way to investigate this problem is to use small molecule chemical tools that mimic the natural chemical messengers. Chemical messengers are produced within a cell and generally do not leak out; small molecule chemical tools can pass in and out of cells easily, so they can be applied to cells, tissues or, in the case of drugs, swallowed as tablets. It is desireable to have chemical tools that modulate the activity of the enzymes such that they inhibit (antagonists) or stimulate (agonists). NAADP is a chemical messenger for which we know little. We previously used computers to screen millions of chemicals to find ones that might affect the proteins responsive to NAADP. We found a compound, Ned-14, that antagonizes NAADP's action. We now want to modify the chemcial structure of Ned-14: (1) to obtain a better antagonist; (2) to find an agonist; and (3) to find antagonists and agonists that are selective for, say, pancreas, heart or neurons. These chemical tools will enable us and our colleagues to learn more about the roles played by NAADP in biology. For example, Ned-14 already has revealed a role for NAADP in the molecular steps linking glucose sensing to insulin release. Not only does this reveal new biology, but might, ultimately, lead to the ideantification of new drug targets and drug-based therapies.
Technical Summary
NAADP (nicotinic acid adenine dinucleotide phosphate) is the most recently discovered calcium-releasing second messenger. As such, much remains to be discovered, but research into the biological roles of NAADP has been hampered by a lack of small molecule tools that are cell permeant and selective. Our interdisciplinary proposal is tightly focused on identifying and validating small molecule tools that act as antagonists and agonists of NAADP action. We propose to use a creative mix of medicinal chemistry and virtual screening to generate analogues of the most potent and selective NAADP antagonist, Ned-14. We will use both sea urchin egg and mammalian cells both to assess biological activity and to probe the presence and function of the hypothesized high- and low-affinity NAADP binding sites. Ned-14 is already the most widely used small molecule tool in the NAADP field, and the development of agonists and next-generation antagonists that are reversible and tissue-selective will greatly broaden experimentation into this important area of research.
Organisations
Publications
Vasudevan SR
(2012)
Shape-based reprofiling of FDA-approved drugs for the H1 histamine receptor.
in Journal of medicinal chemistry
Vasudevan SR
(2010)
The calcium-mobilizing messenger nicotinic acid adenine dinucleotide phosphate participates in sperm activation by mediating the acrosome reaction.
in The Journal of biological chemistry
Vasudevan SR
(2009)
Mining free compound databases to identify candidates selected by virtual screening.
in Expert opinion on drug discovery
Thai TL
(2009)
NAADP receptors mediate calcium signaling stimulated by endothelin-1 and norepinephrine in renal afferent arterioles.
in American journal of physiology. Renal physiology
Taylor L
(2014)
Discovery of novel GPVI receptor antagonists by structure-based repurposing.
in PloS one
Sánchez-Tusie AA
(2014)
Characterization of NAADP-mediated calcium signaling in human spermatozoa.
in Biochemical and biophysical research communications
Ruas M
(2010)
Purified TPC isoforms form NAADP receptors with distinct roles for Ca(2+) signaling and endolysosomal trafficking.
in Current biology : CB
Rosen D
(2009)
Analogues of the nicotinic acid adenine dinucleotide phosphate (NAADP) antagonist Ned-19 indicate two binding sites on the NAADP receptor.
in The Journal of biological chemistry
Pitt SJ
(2010)
TPC2 is a novel NAADP-sensitive Ca2+ release channel, operating as a dual sensor of luminal pH and Ca2+.
in The Journal of biological chemistry
Pascu SI
(2010)
Fluorescent copper(II) bis(thiosemicarbazonates): synthesis, structures, electron paramagnetic resonance, radiolabeling, in vitro cytotoxicity and confocal fluorescence microscopy studies.
in Chemistry, an Asian journal